VJOncology is committed to improving our service to you

ASCO 2019 | The ECOG-ACRIN E2810 study: pazopanib for patients with mRCC

VJOncology is committed to improving our service to you

Elizabeth Plimack

Elizabeth Plimack, MD, MS, of the Fox Chase Cancer Center, Philadelphia, PA talks about The ECOG-ACRIN E2810 (NCT01575548) study that looks at pazopanib for patients with metastatic renal cell carcinoma (mRCC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter